Physician profile
John A Andriulli
NPI 1225063324
$110,801.29
in general payments reported to CMS, 2019-2025
30 companies · $43K in 2025
The $43K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,170 · 2021: $18K · 2022: $1,600 · 2023: $16K · 2024: $13K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $47K · Travel and Lodging: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,086 · Food and Beverage: $5,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $47,293.50 |
| Travel and Lodging | $11,608.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,086.00 |
| Food and Beverage | $5,264.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $79,421.41 | 2019-2025 | Igt Devices Undivided, (9520) Igt Devices Undivided, Igt Devices Systems Undivided |
| Biosense Webster, INC. | $14,201.63 | 2020-2025 | Carto 3, Qdot Micro, Nuvision Ice Catheter |
| Cook Incorporated | $3,560.00 | 2021 | |
| Medtronic Vascular, INC. | $3,411.11 | 2019 | |
| Medtronic, INC. | $3,280.60 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Medical Device Business Services, INC. | $3,260.77 | 2020-2022 | |
| Atricure, INC. | $855.86 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Pharmaceuticals, INC | $694.98 | 2019-2024 | Xarelto |
| Ethicon US, LLC | $662.21 | 2020-2024 | Echelon Circular, Surgicel Nu-Knit, Evarrest |
| Boston Scientific Corporation | $200.42 | 2022-2025 | Bodyguardian, Watchman Access System, Cds - Mct/Cem Monitoring |
| Stryker Corporation | $165.17 | 2025 | Artix Mt, Flowtriever, Ct Thrombectomy System Kit |
| Abbott Laboratories | $153.62 | 2022-2024 | Xience Skypoint |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.65 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $135.92 | 2019-2023 | |
| Bard Access Systems, INC. | $126.62 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $95.80 | 2019 | |
| Pfizer INC. | $60.58 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $54.01 | 2022-2025 | Eliquis |
| Amgen INC. | $51.51 | 2019-2025 | Repatha |
| Inspire Medical Systems, INC. | $32.23 | 2024-2025 | Inspire |
| Abiomed | $29.24 | 2021 | |
| Inari Medical, INC. | $28.90 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Impulse Dynamics (USA) INC. | $28.33 | 2023 | Optimizer |
| Cvrx, INC. | $28.02 | 2023 | Barostim Neo System |
| Vital Connect, INC | $24.69 | 2025 | Vitalpatch Rtm |
| Angiodynamics, INC. | $21.87 | 2019 | |
| Medicomp INC | $20.22 | 2025 | Telepatch Cardiac Monitor |
| Altathera Pharmaceuticals LLC | $17.20 | 2024 | Sotalol Hydrochloride |
| Mirum Pharmaceuticals, INC. | $14.70 | 2025 | Cholbam |
| Kiniksa Pharmaceuticals, LTD. | $14.02 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Andriulli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.